TTHX1114(NM141) in Combination With DWEK/DSO

Completed · Phase 2

Conditions studied: Fuchs' Endothelial Dystrophy, Fuchs Dystrophy, Fuchs

In brief

Open label, single-treatment, with a concurrent non-treatment control

Key facts

Study ID

NCT04676737

Run by

Trefoil Therapeutics, Inc.

People needed

49

Starts

2021-02-01

Expected to finish

2023-01-13

Last updated by the study team

2023-11-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Trefoil Investigational Site 124 — Long Beach, California, United States
• North Bay Eye Associates — Petaluma, California, United States
• Trefoil Investigational Site 123 — Deerfield Beach, Florida, United States
• Trefoil Investigational Site 119 — Fort Myers, Florida, United States
• Price Vision Group — Indianapolis, Indiana, United States
• Tauber Eye Center — Kansas City, Missouri, United States
• Vance Thompson Vision - Bozeman — Bozeman, Montana, United States
• Vance Thompson Vision - Omaha — Omaha, Nebraska, United States
• Vance Thompson Vision - Fargo — West Fargo, North Dakota, United States
• Trefoil Investigational Site 120 — Cincinnati, Ohio, United States
• Vance Thompson Vision - Sioux Falls — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.